Methods: Thirty-six patients (19 males, 17 females; mean age 40.7±11.3 years; range 20 to 68 years) who underwent colored Doppler ultrasound (CDUS) assisted perforating vein ligation with mini-incision due to perforating vein insufficiency between December 2012 and December 2014 were retrospectively analyzed. Symptomatic patients having at least 350 milliseconds of venous reflux during Valsalva maneuver or perforating vein diameter greater than 4 mm in the erect position were included in the study. All affected limbs were classified according to the Clinical- Etiological-Anatomical-Pathophysiological classification system. According to Clinical-Etiological-Anatomical-Pathophysiological classification, 24 patients (66.7%) were C4 (Clinical class 4), five patients (13.9%) were C5, and seven patients (19.4%) were C6. Preoperative and postoperative venous clinical severity scores (VCSS) were calculated and compared. Patients were evaluated with CDUS at postoperative first week and third month.
Results: Mean perforating vein diameter was 4.43±0.35 mm (range 4.0 to 5.1 mm). No intraoperative complications occurred. No severe complications including infection, deep vein thrombosis, paresis, or paresthesia were observed postoperatively. While mean preoperative VCSS score was 12.25±3.6, postoperative VCSS score was 2.25±0.8 with a significant statistical difference (p≤0.05). Venous ulcer was detected in seven patients (19.4%). Mean diameter of venous ulcers was 30±15.2 mm (range 15 to 50 mm). All ulcers were healed postoperatively with a mean healing duration of 2.43±1.2 months.
< b>Conclusion: Colored Doppler ultrasound guided perforating vein ligation with mini-incision is an efficient, simple, and feasible procedure. Thus, it can be a safe alternative to current endovenous thermo-ablative techniques.
The PVs of the leg (Cockett’s perforators) connect the posterior tibial vein with the posterior arch vein (Leonardo’s vein) and are not connected to the GSV.[1] Hence, symptoms due to venous insufficiency do not adequately recover if only the GSV is treated because this does not address the existing PV reflux. Currently, medical treatment, subfascial endoscopic ligation of PVs, percutaneous ablation of the perforators, and CDUS-enhanced ligation with mini incisions are the preferred methods of treatment for this condition.[2-8]
In this manuscript, we present patients with symptomatic venous insufficiency due to PV incompetence who underwent surgery via CDUSassisted ligation with mini incisions. This proved to be a simple, feasible, and efficient method of treatment.
Table 1: Descriptive statistics
Table 3: Venous clinical severity scores
All procedures were performed under the guidance of CDUS in which the straight section of the PV at the level of the fascia was identified. Under local anesthesia, a small incision was made with a No. 11 scalpel, and the PV was explored and gently pulled with the help of a hook. It was then ligated with free silk sutures and dissected. All of the patients were discharged on the postoperative first day and were advised to wear compression stockings and walk at least twice a day for 30 minutes. Furthermore, a non-steroid antiinflammatory drug (NSAID) was prescribed for one week after surgery to combat analgesia.
Statistical analysis
The data was analyzed via the SPSS for Windows
version 15.0 software program (SPSS Inc., Chicago, IL,
USA). The one-sample Kolmogorov-Smirnov test was
used to assess the normality of the continuous variables,
and the statistics for these variables were given as
mean ± standard deviation (SD) or median (minimummaximum).
The categorical variables were shown as
the number of cases and percentages. In addition, the
Wilcoxon test was used to evaluate the significance
of the differences for the two dependent variables,
and the Kruskal-Wallis test was used to determine the
significance between the three independent variables
that were not normally distributed. The Spearman test
was also used to determine any correlations between
the two groups. The results were considered to be
statistically significant with a p value of ≤0.05.
The numbers and sizes of incompetent PVs are correlated with the severity of CVI since with greater severity, the diameter of the PVs becomes wider. This dilatation can be attributed to the elevated venous pressure.[13] Interestingly, in our study, there was no correlation between the VCSS scores and PV diameter, and the close approximation of the range values with respect to the diameter might have been responsible for this debatable outcome. Reducing superficial venous hypertension (HT) leads to more rapid ulcer healing and lower recurrence rates, and this reduction can be achieved by treating the incompetent PVs in CVI.[12] Regarding the CEAP class 4, 5, and 6 patients, the addition of the surgical treatment to treat the incompetent PVs has recently been recognized as being particularly beneficial, and this surgery also keeps 80-90% of the patients free from any ulcer recurrence. However, this ratio decreases to 50% in post-thrombotic syndrome patients.[11] In this study, all of the patients presented as CEAP 4, 5, or 6, and none had this syndrome.
Identifying the PV is easily accomplished via palpation of the fascial defect over the vein. However, CDUS should always be performed after a physical examination by the surgeon to confirm its presence. A cut-off point time of 0.35 seconds and the use of the PV diameter have been suggested as possible criteria for PV incompetence. The clinical importance of the PVs of less than 2 mm is arguable for the diagnosis of reflux even when the reversed flow through them exceeds the cut-off point. Moreover, the technical difficulty of intervention with these PVs is a common problem. Perforating veins that are larger than 4 mm in diameter are always clinically significant and may be identified as incompetent even when the reversed flow through them does not exceed the cut-off point for reflux. However, PVs measuring 2-4 mm in diameter should be considered to be incompetent only when they meet the appropriate hemodynamic criteria.[14-16] In this study, all of the PV diameters were more than 4 mm, and the reflux time was at least 0.35 seconds. The four indications for the interruption of PV insufficiency are presented in Table 4, and only one is needed to indicate the need for treatment.[8]
Table 4: Indications for the interruption of perforating vein insufficiency
Bed rest, leg elevation, local treatment, and compression bandages make up the conservative medical treatment that is usually prescribed for this condition. Although this provides good healing rates in mixed patient groups (C2-C6), the recurrence rates with this type of treatment can be as high as 55-100%.[2] However, t he s imultaneous s urgical treatment of incompetent superficial veins and PVs has been shown to improve recovery and decrease the chance of recurrence compared with the nonsurgical approach in venous ulcer patients. For example, in one critical study, the healing rates were 83% in the surgically treated group and 73% for the patients who received the more conservative course of treatment.[2] Our findings suggest that a combination of medical and surgical therapy is preferable to increase the odds of healing.
Current intervention methods for incompetent PVs include standard open surgery, subfascial endoscopic perforator surgery (SEPS), and percutaneous thermal ablation. Linton’s surgery used to be the preferred form of intervention, but it was abandoned. Currently, CDUS-enhanced PV ligation using a mini-incision via a vein hook is preferable because it is less invasive and very efficient. In addition, it requires no hospitalization. The success rate for this procedure is 95%, and the recurrence rate is only 32% during the first three postoperative years.[3] In our study, the sharp decrease in the VCSS scores after surgery also indicated the success of this technique.
Subfascial endoscopic perforator surgery is minimally invasive and safe. Plus, it has an ulcer healing rate of 88% during the first postoperative year and an ulcer recurrence rate of just 28% after two years.[4] In addition, the patients can be discharged after only a few hours. However, SEPS is considered to be ineffective, especially for retro-malleolar and lateral perforators and for patients with post-thrombotic limbs (46% recurrence rate).[4] There is also a risk of injury for the posterior tibial vessels and tibial nerve, and complications such as DVT (1%), superficial thrombophlebitis (3%), and saphenous neuralgia (7%) have been reported.[13] In addition, wound infection, paresthesia, and subfascial space hematoma have been seen.[8] This method is also expensive and requires a complicated learning curve compared with open surgery techniques. Furthermore, complications such as DVT, superficial thrombophlebitis, and neuralgia are seen more frequently with SEPS.[8]
Thermal and chemical ablation of the saphenous veins can provide a significant reduction in patient discomfort, fewer complications, and an earlier return to work. There is also no need for sedation or anesthesia with this procedure, and it can be performed in the doctor’s office. The occlusion rate for the endovenous laser ablations is reported to be approximately 90%, and complications such as pain (50%), paresthesias (16%), hyperpigmentation (8%), and phlebitis (4%) may be seen along with ecchymosis and induration.[5,17] Radiofrequency ablation is another treatment option. It has an occlusion rate of greater than 90%, and skin burns are very rare with this approach.[6] Sclerotherapy can also be used for PVs with a diameter ranging from 4-7 mm. Contraindications for this type of therapy include allergies to sclerotherapy agents, pregnancy, and patients with prothrombotic tendencies, arterial occlusive disease, or active vasculitis. Sclerotherapy has a 90% occlusion rate,[6] and significantly improved VCSS scores have been noted with this procedure. However, superficial skin necrosis may also occur (1.5%), and the recurrence rate is high (23%).[7] Moreover, anaphylactic shock is a rare and severe complication of sclerotherapy.[7,8] Furthermore, since the PVs usually are accompanied by the perforating arteries (PAs), extra care should be taken to prevent the accidental injection of the sclerosing agents into these arteries.[18]
Declaration of conflicting interests
The authors declared no conflicts of interest with
respect to the authorship and/or publication of this
article.
Funding
The authors received no financial support for the
research and/or authorship of this article.
1) Karla M, Gloviczki P. Endoscopic subfascial ligation of
perforating veins. In: Ascher E, editor. Haimovici’s vascular
surgery. 5th ed. New York: Wiley-Blackwell; 2003. p. 1115-29.
2) van Gent WB, Hop WC, van Praag MC, Mackaay AJ,
de Boer EM, Wittens CH. Conservative versus surgical
treatment of venous leg ulcers: a prospective, randomized,
multicenter trial. J Vasc Surg 2006;44:563-71.
3) van Rij AM, Hill G, Gray C, Christie R, Macfarlane J,
Thomson I. A prospective study of the fate of venous
leg perforators after varicose vein surgery. J Vasc Surg
2005;42:1156-62.
4) Gloviczki P, Bergan JJ, Rhodes JM, Canton LG, Harmsen S,
Ilstrup DM. Mid-term results of endoscopic perforator vein
interruption for chronic venous insufficiency: lessons learned
from the North American subfascial endoscopic perforator
surgery registry. The North American Study Group. J Vasc
Surg 1999;29:489-502.
5) Proebstle TM, Herdemann S. Early results and feasibility
of incompetent perforator vein ablation by endovenous laser
treatment. Dermatol Surg 2007;33:162-8.
6) Eklof B, Kessler D, Kistner RL. Can Duplex-guided
sclerotherapy replace SEPS in the treatment of incompetent
perforating veins? J Vasc Surg 2003;37:545-51.
7) Guex JJ. Ultrasound guided sclerotherapy (USGS) for
perforating veins (PV). Hawaii Med J 2000;59:261-2.
8) Lurie F, Puggioni A. Treatment of perforator vein
insufficiency. In: Cronenwett JL, Johnstin KW, editors.
Rutherford vascular surgery. 7th ed. Philadelphia: Sounders
Company; 2010. p. 1386-99.
9) Vasquez MA, Rabe E, McLafferty RB, Shortell CK,
Marston WA, Gillespie D, et al. Revision of the venous
clinical severity score: venous outcomes consensus
statement: special communication of the American Venous
Forum Ad Hoc Outcomes Working Group. J Vasc Surg
2010;52:1387-96.
10) Labropoulos N, Tassiopoulos AK, Bhatti AF, Leon L.
Development of reflux in the perforator veins in limbs with
primary venous disease. J Vasc Surg 2006;43:558-62.
11) Hissink RJ, Bruins RM, Erkens R, Castellanos Nuijts ML,
van den Berg M. Innovative treatments in chronic venous
insufficiency: endovenous laser ablation of perforating veins:
a prospective short-term analysis of 58 cases. Eur J Vasc
Endovasc Surg 2010;40:403-6.
12) Iriz E, Ereren E, Oktar S, Oktar L, Halit V, Ilhan V. Perforan
venöz yetmezlikte miniflebektomi ile ligasyon. Turk Gogus
Kalp Dama 2009;17:101-5.
13) Gloviczki P. The rationale for the treatment of perforating
veins in advanced chronic venous insufficiency. Dis Mon
2010;56:658-62.
14) Labropoulos N, Tassiopoulos AK, Bhatti AF, Leon L.
Development of reflux in the perforator veins in limbs with
primary venous disease. J Vasc Surg 2006;43:558-62.
15) Mendes RR, Marston WA, Farber MA, Keagy BA. Treatment
of superficial and perforator venous incompetence without
deep venous insufficiency: is routine perforator ligation
necessary? J Vasc Surg 2003;38:891-5.
16) Hastaoglu IO, Tokoz H, Yurdakul I, Bilgen F. Doppler
ultrason ile işaretlenmiş perforan venlerin subfasiyal açık
ligasyonunun yeri: Orta-geç dönem sonuçlarımız. Damar Cer
Derg 2013;22:136-41.